VVT Med Inc. (VVTM : TSX-V)
Common Stock
$0.18
CAD
-0.01 (-5.26%)
Last updated: 2026-06-02
VVTM
VVT Med Inc.
WealthAwesomePerformance
1 Day
-5.26%
1 Week
-5.26%
1 Month
-28.00%
YTD
-35.71%
Key Statistics
Market Cap
$12.70M
52W High
$0.75
52W Low
$0.15
P/E Ratio
-
50 Day MA
$0.23
200 Day MA
$0.29
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/2/2026 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 10,000 |
| 6/1/2026 | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 706 |
| 5/29/2026 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 10,000 |
| 5/28/2026 | $0.18 | $0.19 | $0.18 | $0.19 | $0.19 | 33,009 |
| 5/27/2026 | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 0 |
| 5/26/2026 | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 1,000 |
| 5/25/2026 | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 10,000 |
| 5/21/2026 | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 25,000 |
| 5/20/2026 | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 18,000 |
| 5/14/2026 | $0.23 | $0.23 | $0.18 | $0.21 | $0.21 | 51,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VVTM's historical volatility
30-Day Vol
189.5%
Annualized
90-Day Vol
168.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.17 | C$0.09 – C$0.33 |
| 60 trading days | C$0.16 | C$0.06 – C$0.40 |
| 90 trading days | C$0.15 | C$0.05 – C$0.47 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel.
Financials
- Revenue (TTM)
- $112,000
- EBITDA
- $-1.82M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.07
- Book Value
- -0.01
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report